Loading...
OTCM
PXYN
Market cap6kUSD
Nov 03, Last price  
0.00USD
Name

Praxsyn Corp

Chart & Performance

D1W1MN
OTCM:PXYN chart
P/E
P/S
0.08
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
248.02%
Revenues
81k
-90.06%
0010,11246,40801,348,0001,584,00006,989,00066,599,000819,09181,378
Net income
-566k
L-83.81%
-1,205-16,660-76,252-15,750-804,000-4,056,000-7,514,000-1,219,000230,061-12,354,000-3,496,000-566,000
CFO
-24m
L+1,269.29%
-4,1502,393-64,931-14,146-21,021-2,082,243-1,941,148-284,001-1,732,099-23,717,373

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Praxsyn Corporation operates as a healthcare enterprise, supplying medical professionals with specific medications and related services for their patients. The company specializes in creating non-narcotic and non-habit-forming treatments, utilizing therapeutic and preventative compounds. These come in various formats, such as transdermal creams, patches, and oral capsules, and are formulated to treat issues like pain management, erectile dysfunction, and metabolic disorders. Praxsyn's offerings are available to patients covered by California's workers' compensation program, along with those under preferred provider contracts. Established in 2005, the company was formerly known as The PAWS Pet Company, Inc. before changing its name to Praxsyn Corporation in March 2014. Its operations are based out of Las Vegas, Nevada.
IPO date
Sep 05, 2007
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFY
2018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT